# Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

> **NCT00578097** · PHASE2 · TERMINATED · sponsor: **Ipsen** · enrollment: 81 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00578097
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2009-06
- **Final completion:** 2009-12
- **Target enrollment:** 81 (ACTUAL)
- **Why stopped:** The study was terminated early due to poor recruitment.
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578097, "Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00578097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*